ursodeoxycholic acid has been researched along with Liver Dysfunction in 222 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (8.11) | 18.7374 |
| 1990's | 75 (33.78) | 18.2507 |
| 2000's | 57 (25.68) | 29.6817 |
| 2010's | 57 (25.68) | 24.3611 |
| 2020's | 15 (6.76) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, T; Mo, W; Pan, Z; Ren, H; Wang, F; Xie, M; Xie, Y; Zhou, C | 1 |
| Harpavat, S; Hernandez, J; Hicks, MJ; Killelea, P; Sakhuja, S | 1 |
| Bloks, VW; de Boer, JF; de Vries, HD; Hovingh, MV; Koehorst, M; Kuipers, F; Li, R; Mulder, NL; Palmiotti, A; van Zutphen, T | 1 |
| John, BV; Mansour, N; Shaker, M | 1 |
| Racila, A; Stepanova, M; Younossi, I; Younossi, ZM | 1 |
| Cui, X; Li, X; Li, Y; Lin, Y; Zhu, N | 1 |
| Guan, L; Li, X; Li, Y; Lin, X; Wang, N; Zhang, X | 1 |
| Liu, T; Wang, JS | 1 |
| Bedossa, P; Bowlus, CL; Drenth, JPH; Forman, LM; Iloeje, U; Jin, Y; Kremer, AE; Liberman, A; MacConell, L; Parés, A; Pencek, R; Pockros, PJ; Ryder, SD; Terracciano, L | 1 |
| Combalia, A; Dubreuil, M; Guañabens, N; Jurado, S; Monegal, A; Parés, A; Peris, P; Ruiz-Gaspà, S | 1 |
| Banales, JM; Briz, O; Bujanda, L; Caballero-Camino, FJ; Cossío, FP; Esteller, M; Gradilone, SA; Herraez, E; Izquierdo-Sanchez, L; Jin, S; Lee-Law, PY; Marin, JJG; Munoz-Garrido, P; Peixoto, E; Perugorria, MJ; Richard, S; Rivilla, I; Rodrigues, PM; Santos-Laso, A | 1 |
| Staufer, K | 1 |
| Anderson, KE; Center, SA; Choi, AE; Kunz, BC; Randolph, JF; Walker, JD | 1 |
| Aldigeri, R; Battaglia, L; Gelsi, E; Quintavalla, F; Ramoni, R | 1 |
| Barbier, O; Cieślak, A; Gobeil, S; Perreault, M; Thérien, A; Trottier, J; Verreault, M; Vohl, MC | 1 |
| Beuers, U; Hohenester, S | 1 |
| Bertolini, A; Bodewes, FAJA; Jonker, JW; van de Peppel, IP; Verkade, HJ | 1 |
| Ashby, D; Cheng, K; Smyth, RL | 3 |
| Kim, HS; Kim, JS; Lee, DK; Lee, JH; Lim, JH | 1 |
| Vollmer, H | 1 |
| Al Qatarneh, S; Lindblad, D; Michel, HK; Ozolek, J; Venkat, V; Weiner, DJ | 1 |
| Boëlle, PY; Clement, A; Corvol, H; Debray, D; Guillot, L | 1 |
| Blomenkamp, KS; Fickert, P; Tang, Y; Teckman, JH; Trauner, M | 1 |
| Cho, JY; Chung, JY; Jang, IJ; Ji, SC; Kim, DJ; Kim, YK; Lee, S; Yang, J; Yoon, S; Yu, KS | 1 |
| Poupon, R | 1 |
| Lenzi, M; Muratori, L; Muratori, P | 1 |
| Amelung, L; Arends, JE; de Bruijne, J; Leoni, MC; Lieveld, FI; van den Brink, J; van Erpecum, CP; van Erpecum, KJ | 1 |
| Bancel, B; Brunel, T; Goubault, P; Mabrut, JY; Mohkam, K; Rode, A | 1 |
| Heller, T; Kleiner, DE; Koh, C; Sakiani, S | 1 |
| Herrera, JL; Kumar, M | 1 |
| Arab, JP; Arrese, M; Cabrera, D | 1 |
| Hagymási, K; Tulassay, Z | 1 |
| Fan, D; Han, Y; Han, Z; Huang, X; Li, T; Li, Z; Shi, Y; Wang, J; Wang, L; Wang, M; Wang, R; Wang, X; Zhou, X | 1 |
| Grigor'eva, GA; Meshalkina, NIu | 1 |
| Fisher, SE; Rabinowitz, SS; Schwarz, SM; Vo, HD; Xu, J | 1 |
| Drozdova, LIu; Iakhontov, DA; Kutishenko, NP; Lerman, OV; Martsevish, SIu; Nevzorova, VA; Reznik, II; Shavkuta, GV | 1 |
| Radchenko, VG; Seliverstov, PV; Sitkin, SI | 1 |
| Banales, JM; Beuers, U; Bujanda, L; Concepcion, AR; Drenth, JP; Erice, O; Hijona, E; Jimenez-Agüero, R; LaRusso, NF; Marin, JJ; Marzioni, M; Masyuk, TV; Monte, MJ; Munoz-Garrido, P; Perugorria, MJ; Portu, A; Prieto, J; Romero, MR; Sáez, E; Santos-Laso, Á; Sarvide, S; Úriz, M; Urribarri, AD | 1 |
| Claudel, T; Fickert, P; Fuchs, C; Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Krones, E; Moustafa, T; Munda, P; Paumgartner, G; Pollheimer, M; Steinacher, D; Trauner, M; Traussnigg, S | 1 |
| Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Iijima, T; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y | 1 |
| Higashi, T; Kariyama, K; Kishida, M; Nishimura, M; Nouso, K; Wada, N; Wakuta, A | 1 |
| Cecchi, N; Garzi, A; Mandato, C; Orso, G; Vajro, P; Veropalumbo, C | 1 |
| Drzymała-Czyż, S; Jończyk-Potoczna, K; Lisowska, A; Stajgis, M; Walkowiak, J | 1 |
| Chang, JW; Chen, JS; Hsu, HC; Huang, WK; Kuo, CF; Lin, YC; Liu, JR; See, LC; Yang, TS; Yu, KH | 1 |
| Banales, JM; Beuers, U; Brunenberg, EJ; Bujanda, L; D'Agnolo, HM; Drenth, JP; Kievit, W; Neijenhuis, MK; Riaño, I; Takkenberg, RB | 1 |
| Alicandro, G; Biffi, A; Colombo, C; Corti, F; Crosignani, A; Motta, V; Setchell, KDR; Zhang, W | 1 |
| Narkewicz, MR | 1 |
| Alawad, AS; Levy, C | 1 |
| Ayadi, S; Bougassas, W; Cheikh, M; Ennaifer, R; Hadj, NB; Nejma, HB; Romdhane, H | 1 |
| Halilbasic, E; Steinacher, D; Trauner, M | 1 |
| Azzaroli, F; Colecchia, A; Di Biase, AR; Festi, D; Lodato, F; Mazzella, G; Montagnani, M; Roda, A; Roda, E; Simoni, P | 1 |
| Moreno Villares, JM | 1 |
| Blum, HE; Panther, E | 1 |
| Bernard, O; Broué, P; Dabadie, A; Ducot, B; Jacquemin, E; Lachaux, A; Lykavieris, P; Sarles, J | 1 |
| González-Gallego, J; Mauriz, JL; Tuñón, MJ | 1 |
| Adam, R; Reinshagen, K; Trunk, M; Wessel, LM | 1 |
| Cooper, J; Webster, CR | 1 |
| Akoglu, B; Faust, D; Milovic, V; Ristic, G | 1 |
| Decock, S; Hirschfield, GM; McGee, P | 1 |
| Houwen, RH; Klomp, LW; Stapelbroek, JM; van Erpecum, KJ | 1 |
| Boggia, B; Buonpensiero, P; De Gregorio, F; Di Pasqua, A; Ferri, P; Raia, V; Sepe, A; Siano, M | 1 |
| Brodlie, S; Carroll, J; Cowles, RA; Harren, PA; Jan, DM; Lobritto, SJ; Martinez, M; Ventura, KA | 1 |
| Gunji, N; Irisawa, A; Ishihata, R; Kaise, S; Ohira, H; Saito, A; Takano, M; Utsumi, Y | 1 |
| Alaggio, R; D'Antiga, L; Giordano, G; Guido, M; Riello, L; Zancan, L | 1 |
| Aygören, R; Günşar, C; Mir, E; Sencan, A; Türköz, E; Var, A; Vatansever, S; Yilmaz, O | 1 |
| Baussan, C; Davit-Spraul, A; Gonzales, E; Jacquemin, E | 1 |
| Amaral, JD; Rodrigues, CM; Steer, CJ; Xavier, JM | 1 |
| Il'chenko, AA | 2 |
| Dockter, G; Herrmann, U; Lammert, F | 1 |
| Beuers, U; Denk, GU; Ferdinandusse, S; Fickert, P; Fuchsbichler, A; Hofmann, AF; Invernizzi, P; Kulik, W; Maitz, S; Rust, C; Trauner, M; Wimmer, R | 1 |
| Giljaca, V; Gluud, C; Poropat, G; Stimac, D | 1 |
| Golovanova, EV; Noskova, KK; Petrakov, AV | 1 |
| Bozdag, S; Dilmen, U; Erdeve, O; Gokmen, T; Oguz, SS; Uras, N | 1 |
| Baughman, RP; Cremers, JP; Drent, M; Koek, GH; Wijnen, PA | 1 |
| Bakker, GJ; Beuers, U; Haan, YC; Maillette de Buy Wenniger, LJ | 1 |
| Poupon, R; Serfaty, L | 1 |
| Duggan, C; Raphael, BP | 1 |
| Beuers, U; Paumgartner, G | 2 |
| Eriksson, B; Hägglund, H; Juvonen, E; Parkkali, T; Remberger, M; Remes, K; Ringdén, O; Ruutu, T; Volin, L | 1 |
| Cortes, J; Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; Thomas, D | 1 |
| Adler, G; Reinshagen, M | 1 |
| Knottenbelt, CM; McGrotty, YL; Ramsey, IK | 1 |
| Burroughs, AK; Mancuso, A; Mela, M | 1 |
| Matsuzaki, Y; Nishikawa, K | 1 |
| Beuers, U; Dilger, K; Hempfling, W | 1 |
| Iida, N; Koike, M; Ogawa, K; Oshimi, K; Sekigawa, I | 1 |
| Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C | 1 |
| Hoskins, AC; Lewindon, PJ; O'Connell, NC; Pereira, TN; Ramm, GA; Setchell, KD; Shepherd, RW; Smith, JL | 1 |
| Blum, HE | 1 |
| Bueverov, AO | 1 |
| Alenezi, B; Alpert, L; Lamoureux, E; Szilagyi, A | 1 |
| Gondo, H; Harada, M; Hashiguchi, M; Higuchi, M; Imamura, R; Kato, K; Kuroiwa, M; Nagafuji, K; Ogata, H; Okamura, T; Oku, E; Ono, N; Otsubo, K; Sata, M; Seki, R; Shibuya, T; Taniguchi, S; Yakushiji, K; Yoshimoto, K | 1 |
| Akan, H; Arat, M; Erden, E; Idilman, R; Karayalçin, S; Soydan, EA; Soykan, I | 1 |
| Fickert, P; Geier, A; Trauner, M | 1 |
| Brok, J; Gluud, C; Gong, Y; Koretz, RL | 1 |
| Adams, PC; Assy, N; Ghent, CN; Minuk, GY; Myers, P; Simon, V; Wall, W | 1 |
| Il'chenko, LIu; Mikheeva, OM | 1 |
| Allard, JP; Raman, M | 1 |
| Fukunari, A; Imada, T; Ishizaki, K; Iwaki, T; Kinoshita, S; Tanaka, H; Tsurufuji, M | 1 |
| Chiba, K; Fukunari, A; Imada, T; Ishizaki, K; Iwaki, T; Kinoshita, S; Koyama, M; Maeda, Y; Sakata, K; Tanaka, H; Tsurufuji, M | 1 |
| Duarte-Rojo, A; Martínez-Benítez, B; Sánchez-Osorio, M; Torre, A; Uribe, M | 1 |
| Avsar, E; Aygun, C; Celikel, C; Eren, F; Haklar, G; Hulagu, S; Senturk, O; Tahan, V; Tozun, N; Unluguzel, G; Uraz, S; Yuksel, M | 1 |
| Gabe, SM; Lloyd, DA | 1 |
| Bailey, M; Clark, D; Desmond, CP; Roberts, SK; Wilson, J | 1 |
| Alexander, GJ; Allison, ME; Bilton, D; Haworth, CS; Lomas, DJ; McKeon, D; Nash, KL | 1 |
| Shan, RB; Zhu, MZ | 1 |
| Chernyshev, AL; Maksimov, VA; Shelemov, EE | 1 |
| Barois, A; Bataille, J; Do Ngoc Thanh, C; Estournet-Mathiaud, B; Ioos, C | 1 |
| Hofmann, AF; van Berge-Henegouwen, GP | 1 |
| Miescher, G; Paumgartner, G; Preisig, R | 1 |
| Imawari, M; Matsuzaki, Y; Mitamura, K; Osuga, T; Shoda, J | 1 |
| Buffet, C; Chaput, JC; Etienne, JP; Franco, D; Houssin, D; Labayle, D | 1 |
| Bull, HJ; Coltart, DJ; Gilmore, IT; Marigold, JH; Thompson, RP | 1 |
| Inaguma, H | 1 |
| Baker, D; Gochman, N; Javitt, NB; Jones, HM; Miyai, K | 1 |
| Shinozaki, K | 1 |
| Fukushima, K; Hino, K; Ohashi, K; Yamamoto, S; Yamashita, S | 1 |
| Allan, RN; Dew, MJ; Huybregts, AW; van Berge Henegouwen, GP | 1 |
| Stiehl, A | 2 |
| Blanc, P; Domergue, J; Fabre, JM; Larrey, D; Michel, H; Navarro, F; Pageaux, GP; Perrigault, PF; Souche, B | 1 |
| Tanner, MS; Taylor, CJ | 1 |
| Batta, AK; Chen, T; Kren, BT; Nguyen, LB; Salen, G; Shefer, S; Steer, CJ; Tint, GS | 1 |
| Cerrè, C; Forti, GC; Gioacchini, AM; Natalini, B; Pellicciari, R; Polimeni, C; Roda, A; Sadeghpour, B; Sapigni, E | 1 |
| Eriksson, S; Sahlin, S | 1 |
| Kawasaki, H; Murawaki, Y | 1 |
| Kimura, A; Makino, I; Nakamura, K | 1 |
| Angelico, M; Antonelli, M; Bertasi, S; De Santis, A; Diamanti, S; Goffredo, F; Martino, F; Merli, M; Quattrucci, S; Servi, R | 1 |
| Hofmann, AF | 2 |
| Lindblad, A; Strandvik, B | 1 |
| Leuschner, U | 1 |
| Enomoto, M; Sadamoto, T; Sato, G; Shibata, M; Tuzimoto, S; Ueno, Y; Watanabe, M; Yamagami, T; Yasushi, T | 1 |
| Michael, S; Simko, V | 1 |
| Loizeau, E | 1 |
| Montet, JC; Queneau, PE | 1 |
| van Berge-Henegouwen, GP; Van de Meeberg, PC; van Erpecum, KJ | 1 |
| Khandelwal, M; Kowalski, TE; Malet, PF; Rubin, RA | 1 |
| Luketic, VA; Sanyal, AJ | 1 |
| Cirillo, NW; Zwas, FR | 1 |
| van Berge Henegouwen, GP; van de Meeberg, PC; van Erpecum, KJ | 1 |
| Apostolo, MG; Bettinardi, N; Colombo, C; Crosignani, A; Giunta, A; Marzano, MT | 1 |
| Hotta, H; Makino, I; Nakamura, K | 1 |
| Alonso, JR; Badia, MD; el-Mir, MY; Marin, JJ; Monte, MJ; Palomero, F | 1 |
| Ansari, GG; Cosentino, CM; Das, JB; Levy, MF; Raffensperger, JG | 1 |
| Carughi, S; Lucentini, L; Sperandeo, G; Sperandeo, M; Varriale, A | 1 |
| Bowler, IM; Irving, HC; Littlewood, JM; O'Connor, PJ; Robinson, PJ; Southern, KW | 1 |
| Manns, MP; Schmidt, HH | 1 |
| Battezzati, PM; Bettinardi, N; Colombo, C; Giunta, A; Podda, M | 1 |
| Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
| Dingemans, KP; Elferink, RP; Groen, AK; Offerhaus, GJ; Ottenhoff, R; Tytgat, GN; Van Den Bergh Weerman, MA; Van Nieuwkerk, CM | 1 |
| Aoshima, M; Fujita, M; Hasegawa, T; Kato, T; Kimura, A; Makino, I; Nakamura, K; Saito, H; Sato, Y; Tamori, K; Yokohama, S; Yoneda, M | 1 |
| Crosignani, A; Invernizzi, P; Larghi, A; Podda, M; Rodrigues, CM; Setchell, KD | 1 |
| Burke, AF; Campbell, GR; FitzGerald, MX; Hegarty, JE; Maguire, OC; O'Brien, SM; Rowlands, BJ | 1 |
| Aversa, F; Balo', S; Clerici, C; Gentili, G; Martelli, M; Modesto, R; Morelli, A; Morselli-Labate, AM; O'Connell, N; Rusticali, G; Setchell, KD | 1 |
| Bateson, MC | 1 |
| Sheptulin, AA | 1 |
| Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM | 1 |
| Saksena, S; Tandon, RK | 1 |
| Attar, A; Aubertin, JM; Bécheur, H; Bloch, F; Charton-Bain, MC; Chatellier, G; Dall'osto, H; Petite, JP | 1 |
| Groen, AK; Offerhaus, JJ; Ottenhoff, R; Oude Elferink, RP; Tytgat, GN; van den Bergh Weerman, MA; van Nieuwerk, CM; van Wijland, M | 1 |
| Balistreri, WF | 1 |
| Ashby, D; Cheng, K; Smyth, R | 2 |
| Glaumann, H; Lindblad, A; Strandvik, B | 1 |
| Doss, MO; Frank, M; Gross, U | 1 |
| Battezzati, PM; Colombo, C; Podda, M; Strazzabosco, M | 1 |
| Berenguer Lapuerta, J; Pérez-Aguilar, F | 1 |
| Benz, C; Sauer, P; Stiehl, A | 1 |
| García, N; Martí-Climent, JM; Medina, JF; Peñuelas, I; Prieto, J; Richter, JA | 1 |
| Graziadei, IW; Trauner, M | 1 |
| Battezzati, PM; Castellani, MR; Colombo, C; Comi, S; Crosignani, A; Giunta, A; Melzi, ML | 1 |
| Bernard, O; Estournet-Mathiaud, B; Fabre, M; Grangeponte, MC; Labrune, P; Maurage, C; Rambaud, C; Trioche, P | 1 |
| Kowdley, KV | 1 |
| Carpenter, HA; Czaja, AJ; Moore, SB; Santrach, PJ | 1 |
| Aragione, N; Franzese, A; Iannucci, MP; Vajro, P; Valerio, G | 1 |
| Sokol, RJ | 1 |
| Kumar, D; Tandon, RK | 1 |
| Economou, H; Fotoulaki, M; Galli-Tsinopoulou, A; Nousia-Arvanitakis, S; Xefteri, M | 1 |
| Gish, RG; Mason, A | 1 |
| Gores, GJ; Lazaridis, KN; Lindor, KD | 1 |
| Aldini, R; Azzaroli, F; Montagnani, M; Piazza, F; Roda, A; Roda, E; Russo, C | 1 |
| Anan'eva, NP; Drondina, AK; Nikitina, TS; Reĭzis, AR; Stulov, AP | 1 |
| Angulo, P | 1 |
| Btaiche, IF; Khalidi, N | 1 |
| Chayama, K; Tazuma, S | 1 |
| Aoki, T; Araki, H; Date, S; Fujito, A; Imada, N; Imaide, Y; Iwamoto, N; Kamoi, K; Kitamori, T; Kitamura, K; Kojima, M; Mikami, K; Miki, T; Miyashita, H; Nakao, M; Ohe, H; Saitoh, M; Takada, H; Tanaka, S; Uchida, M; Ukimura, O | 1 |
| Olsson, R | 1 |
| Tangedahl, T | 1 |
| Guma, C; Viola, L | 1 |
| Assaisso, M; Battezzati, PM; Colombo, C; Crosignani, A; Giunta, A; Podda, M; Setchell, KD; Zimmer-Nechemias, L | 1 |
| Erlinger, S | 1 |
| Buongiorno, G; Guerra, V; Manghisi, OG; Misciagna, G; Quaranta, GM | 1 |
| Apostolo, MG; Assaisso, M; Bottani, P; Colombo, C; Roman, B | 1 |
| Lerner, A; Rivlin, J | 1 |
| Fisher, LD; Fried, RH; McDonald, GB; Murakami, CS; Sullivan, KM; Willson, RA | 1 |
| Assaisso, ML; Balistreri, WF; Castellani, MR; Colombo, C; Giunta, A; Seregni, E | 1 |
| Tanner, MS | 1 |
| Egestad, B; Marschall, HU; Matern, H; Matern, S; Sjövall, J; Wietholtz, H | 1 |
| Cho, HM; Choi, SW; Chung, KW; Han, JH; Kim, BS; Lim, KT; Park, DH; Seo, EJ; Sun, HS | 1 |
| de Caestecker, JS; Jazrawi, RP; Northfield, TC; Petroni, ML | 1 |
| Beuers, U; Fischer, S; Paumgartner, G; Spengler, U | 1 |
| Irifune, H; Nonaka, S; Tsukazaki, N; Watanabe, M | 1 |
| Heuman, DM; Hylemon, PB; McCall, J; Mills, AS; Pandak, WM; Vlahcevic, ZR | 1 |
| van Berge Henegouwen, GP; van Erpecum, KJ | 1 |
| Berenson, MM; Garcia-Marin, JJ; Welch, V | 1 |
| Berenson, MM; Bjorkman, DJ; Gunther, C; Samowitz, WS | 1 |
| Colombo, C; Nakagawa, M; Setchell, KD | 1 |
| Colombo, C; Crosignani, A; Curcio, L; Giunta, A; Podda, M; Roda, A; Ronchi, M; Setchell, KD | 1 |
| Bäcker, U; Doss, MO; Meessen, D; Schmidt, FW; Wagner, S; Wittekind, C | 1 |
| Hayakawa, T; Hoshino, M; Katagiri, K; Kawamura, Y; Miyani, M; Nakai, T; Ohnishi, H; Shiraka, S; Takeshima, A; Tsukada, K | 1 |
| Ban, N; Kawasaki, T; Kimura, T; Moriyasu, F; Nakamura, T; Ono, S; Tamada, T; Uchino, H; Yamashita, Y | 1 |
| Ishizaki, T; Kubota, K; Makino, I; Nakagawa, S; Shinozaki, K; Yamaguchi, A; Yamaoka, K | 1 |
| Cohen, BI; Hagey, LR; Hofmann, AF; Mosbach, EH; Rothschild, MA; Stenger, RJ; Yoon, YB | 1 |
| Goszcz, A | 1 |
| Luciani, A; Massari, M; Montanari, P; Nora, A; Zandomeneghi, R | 1 |
87 review(s) available for ursodeoxycholic acid and Liver Dysfunction
| Article | Year |
|---|---|
Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis.
Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Prognosis; Ursodeoxycholic Acid | 2022 |
Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.
Topics: Adult; Cholangitis, Sclerosing; Colitis, Ulcerative; Connective Tissue Diseases; Hepatitis, Autoimmune; Humans; Liver Diseases; Male; Syndrome; Ursodeoxycholic Acid | 2023 |
Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid | 2020 |
[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
Topics: Adult; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Humans; Liver Diseases; Ursodeoxycholic Acid | 2017 |
Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
Topics: Aftercare; Aminophenols; Aminopyridines; Benzodioxoles; Chloride Channel Agonists; Cholagogues and Choleretics; Cystic Fibrosis; Drug Combinations; Elasticity Imaging Techniques; Humans; Liver Diseases; Liver Transplantation; Quinolones; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Nutritional Status; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review.
Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B; Bile; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis; Cholangitis, Sclerosing; Cholecystectomy; Cholelithiasis; Codon, Nonsense; Diagnosis, Differential; Female; Gallstones; Humans; Lithiasis; Liver Abscess; Liver Cirrhosis, Biliary; Liver Diseases; Mutation; Phosphatidylcholines; Pregnancy; Pregnancy Complications; Recurrence; Syndrome; Ultrasonography; Ursodeoxycholic Acid | 2019 |
Hepatic Manifestations of Cystic Fibrosis.
Topics: Cholagogues and Choleretics; Cystic Fibrosis; Diagnosis, Differential; Humans; Hypertension, Portal; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid | 2019 |
Sarcoidosis and the Liver.
Topics: Adrenal Cortex Hormones; Cholagogues and Choleretics; Diagnosis, Differential; Humans; Liver Diseases; Liver Transplantation; Sarcoidosis; Ursodeoxycholic Acid | 2019 |
UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
Topics: Bile Acids and Salts; Cholestasis; Humans; Liver; Liver Diseases; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2019 |
[Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties].
Topics: Adrenal Cortex Hormones; Autoantibodies; Autoimmunity; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Syndrome; Ursodeoxycholic Acid | 2013 |
The liver in pediatric gastrointestinal disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Infant; Inflammatory Bowel Diseases; Infliximab; Liver Diseases; Liver Function Tests; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2014 |
[New aspects of pharmacological effects of ursodeoxycholic acid].
Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.
Topics: Animals; Bile Duct Diseases; Humans; Liver Diseases; Metabolic Diseases; Signal Transduction; Ursodeoxycholic Acid | 2015 |
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Topics: Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Acids, Omega-3; Fish Oils; Humans; Infant; Infant, Newborn; Liver Diseases; Parenteral Nutrition; Soybean Oil; Ursodeoxycholic Acid | 2016 |
AISF position paper on liver disease and pregnancy.
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Budd-Chiari Syndrome; Calcium Channel Blockers; Cholagogues and Choleretics; Cholelithiasis; Cholestasis, Intrahepatic; Eclampsia; Fatty Liver; Female; Fluid Therapy; HELLP Syndrome; Hepatitis, Viral, Human; Humans; Hyperemesis Gravidarum; Italy; Liver Diseases; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Societies, Medical; Thiamine; Ursodeoxycholic Acid; Viral Hepatitis Vaccines; Vitamin B Complex | 2016 |
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
Topics: Animals; Cholestasis; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Liver Diseases; Metabolic Diseases; Ursodeoxycholic Acid | 2017 |
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
Topics: Animals; Bile Acids and Salts; Biological Transport, Active; Child; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Pregnancy; Ursodeoxycholic Acid | 2007 |
[Parenteral nutrition-associated liver disease].
Topics: Age Factors; Cholagogues and Choleretics; Cholestasis; Enteral Nutrition; Humans; Infant, Newborn; Infant, Premature; Liver Diseases; Parenteral Nutrition; Risk Factors; Short Bowel Syndrome; Time Factors; Ursodeoxycholic Acid | 2008 |
[Liver diseases in pregnancy].
Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Delivery, Obstetric; Fatty Liver; Female; HELLP Syndrome; Humans; Hyperemesis Gravidarum; Liver Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2008 |
Apoptotic signaling pathways as a target for the treatment of liver diseases.
Topics: Animals; Apoptosis; Atorvastatin; Gliotoxin; Heptanoic Acids; Humans; Liver Diseases; Molecular Conformation; Pyrroles; Signal Transduction; Ursodeoxycholic Acid | 2008 |
The chronic liver disease in patients with short bowel syndrome: etiology and treatment.
Topics: Anti-Bacterial Agents; Child; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Enteral Nutrition; Evidence-Based Medicine; Humans; Infant, Newborn; Infant, Premature; Intestine, Small; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Home; Practice Guidelines as Topic; Prognosis; Risk Factors; Sepsis; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease.
Topics: Acetylcysteine; Animals; Antioxidants; Biliary Tract Diseases; Cat Diseases; Cats; Cholagogues and Choleretics; Cryoprotective Agents; Dog Diseases; Dogs; Free Radical Scavengers; Liver Diseases; S-Adenosylmethionine; Silymarin; Ursodeoxycholic Acid; Vitamin E | 2009 |
Autoimmune liver disease for the non-specialist.
Topics: Autoimmune Diseases; Cholagogues and Choleretics; Family Practice; Humans; Liver Diseases; Nurse Clinicians; Nurse's Role; Ursodeoxycholic Acid | 2009 |
Liver disease associated with canalicular transport defects: current and future therapies.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Bile; Bile Canaliculi; Biliary Tract Surgical Procedures; Biological Transport, Active; Cholestyramine Resin; Genetic Therapy; Humans; Lipoproteins; Liver Diseases; Liver Transplantation; Models, Biological; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Mutation; Rifampin; Ursodeoxycholic Acid | 2010 |
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cholestasis, Intrahepatic; Female; Genes, MDR; Genetic Predisposition to Disease; Humans; Infant, Newborn; Jaundice, Neonatal; Liver Diseases; Liver Transplantation; Mutation; Mutation, Missense; Phenotype; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2010 |
Targeting the p53 pathway of apoptosis.
Topics: Animals; Apoptosis; Cholagogues and Choleretics; Drug Design; Humans; Liver Diseases; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2010 |
Cystic fibrosis-associated liver disease.
Topics: Animals; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Portasystemic Shunt, Transjugular Intrahepatic; Ursodeoxycholic Acid | 2010 |
Bile acids for primary sclerosing cholangitis.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2011 |
Therapeutic approach of hepatic sarcoidosis.
Topics: Antioxidants; Humans; Liver Diseases; Prednisone; Sarcoidosis; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2012 |
[The substantiation of UDCA usage in functional disorders of biliary tract].
Topics: Animals; Gallbladder Diseases; Humans; Liver Diseases; Ursodeoxycholic Acid | 2011 |
Sarcoidosis of the liver: to treat or not to treat?
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Cholagogues and Choleretics; Fatigue; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Prednisolone; Pruritus; Sarcoidosis; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Topics: Cholagogues and Choleretics; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 2002 |
[Extraintestinal manifestations].
Topics: Amyloidosis; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cohort Studies; Controlled Clinical Trials as Topic; Crohn Disease; Cross-Sectional Studies; Drug Therapy, Combination; Eye Diseases; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Calculi; Kidney Diseases; Liver Diseases; Longitudinal Studies; Lung Diseases; Nervous System Diseases; Osteoporosis; Pancreatitis; Placebos; Prospective Studies; Retrospective Studies; Risk; Risk Factors; Skin Diseases; Thromboembolism; Ursodeoxycholic Acid | 2003 |
Review article: pruritus in cholestatic and other liver diseases.
Topics: Anion Exchange Resins; Antipruritics; Cholagogues and Choleretics; Humans; Liver Diseases; Narcotic Antagonists; Ondansetron; Pruritus; Rifampin; Ursodeoxycholic Acid | 2003 |
[Therapeutic options for drug induced liver injury: the efficacy of UDCA based on EBM].
Topics: Androgen Antagonists; Animals; Chemical and Drug Induced Liver Injury; Evidence-Based Medicine; Flutamide; Liver Diseases; Rats; Ursodeoxycholic Acid | 2003 |
Systematic review: ursodeoxycholic acid--adverse effects and drug interactions.
Topics: Cholagogues and Choleretics; Chronic Disease; Drug Interactions; Female; Humans; Liver Diseases; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2003 |
[Autoimmune liver disease: diagnosis and therapy].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Immunoassay; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prognosis; Ultrasonography; Ursodeoxycholic Acid | 2004 |
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Topics: Cholestasis; Enterohepatic Circulation; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
[Hepatitis 2004: an update].
Topics: Antiviral Agents; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis, Alcoholic; Humans; Laparoscopy; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Physical Examination; Ultrasonography; Ursodeoxycholic Acid; Weight Loss | 2004 |
Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
Topics: Adult; Cholagogues and Choleretics; Female; Granuloma; Humans; Liver Diseases; Sarcoidosis; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
Topics: Adrenal Cortex Hormones; Bacterial Infections; Bile; Bile Ducts; Cholestasis; Cytokines; Humans; Liver; Liver Diseases; Liver Transplantation; Nitric Oxide; Sepsis; Ursodeoxycholic Acid | 2006 |
Hepatology may have problems with putative surrogate outcome measures.
Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load | 2007 |
Parenteral nutrition related hepato-biliary disease in adults.
Topics: Adult; Anti-Bacterial Agents; Biliary Tract Diseases; Cholestasis; Fatty Liver; Gallstones; Hepatitis; Humans; Intestines; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Ursodeoxycholic Acid | 2007 |
Managing liver dysfunction in parenteral nutrition.
Topics: Anti-Bacterial Agents; Cholestasis; Enteral Nutrition; Humans; Liver Diseases; Parenteral Nutrition; Risk Factors; Sepsis; Ursodeoxycholic Acid | 2007 |
[Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis].
Topics: Cholestasis; Female; Humans; Liver Diseases; Male; Neonatology; Parenteral Nutrition, Total; S-Adenosylmethionine; Ursodeoxycholic Acid | 2008 |
Systemic spill-over of bile acids.
Topics: Bile Acids and Salts; Enterohepatic Circulation; Humans; Kinetics; Liver Diseases; Ursodeoxycholic Acid | 1983 |
[Bile acids in liver diseases--current indications].
Topics: Bile Acids and Salts; Biliary Atresia; Child; Cholangitis, Sclerosing; Female; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1995 |
Liver disease in cystic fibrosis.
Topics: Adolescent; Adult; Bile Duct Diseases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Susceptibility; Genetic Therapy; Humans; Liver Diseases; Membrane Proteins; Ursodeoxycholic Acid | 1995 |
[Various problems in therapy and prognosis of drug-induced liver diseases].
Topics: Chemical and Drug Induced Liver Injury; Diet, Fat-Restricted; Drug-Related Side Effects and Adverse Reactions; Humans; Liver Diseases; Phenobarbital; Prednisolone; Prognosis; Ursodeoxycholic Acid | 1995 |
Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
Topics: Bile Acids and Salts; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Cystic fibrosis. Is treatment with ursodeoxycholic acid of value?
Topics: Animals; Clinical Trials as Topic; Cystic Fibrosis; Gallbladder Diseases; Humans; Liver Diseases; Liver Function Tests; Ursodeoxycholic Acid | 1994 |
[Bile acids in therapy of liver diseases].
Topics: Chronic Disease; Dose-Response Relationship, Drug; Humans; Liver Diseases; Ursodeoxycholic Acid | 1994 |
[Ursodeoxycholic acid: hope in the treatment of liver diseases].
Topics: Animals; Cholangitis, Sclerosing; Cholelithiasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Postcholecystectomy Syndrome; Rats; Ursodeoxycholic Acid | 1994 |
Hepatoprotection by hydrophilic bile salts.
Topics: Bile Acids and Salts; Cholangitis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Therapy with ursodeoxycholic acid in cholestatic liver disease.
Topics: Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Postoperative Care; Pregnancy; Pregnancy Complications; Recurrence; Ursodeoxycholic Acid | 1993 |
Ursodiol for hepatobiliary disorders.
Topics: Animals; Cholelithiasis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 1994 |
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid in the treatment of chronic liver disease.
Topics: Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Hepatitis, Chronic; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 1994 |
Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease.
Topics: Bile Acids and Salts; Cholestasis; Enterohepatic Circulation; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1993 |
Oral bile acids in cystic fibrosis-associated liver disease.
Topics: Administration, Oral; Clinical Trials as Topic; Cystic Fibrosis; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Liver Diseases; Pilot Projects; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 1994 |
[Bile acids in the therapy of chronic liver diseases].
Topics: Chronic Disease; Hepatitis, Chronic; Humans; Liver Diseases; Ursodeoxycholic Acid | 1993 |
Clinical pharmacokinetics of therapeutic bile acids.
Topics: Absorption; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Chronic Disease; Humans; Injections, Intravenous; Liver; Liver Diseases; Ursodeoxycholic Acid | 1996 |
[New gastroenterological prospects of ursodeoxycholic acid].
Topics: Bile; Dose-Response Relationship, Drug; Gallbladder Diseases; Gastrointestinal Agents; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid in the treatment of liver diseases.
Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Chronic Disease; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Diseases; Liver Transplantation; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid.
Topics: Adolescent; Adult; Bile Acids and Salts; Biliary Tract Diseases; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Pregnancy; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.
Topics: Cholagogues and Choleretics; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
Liver and biliary problems in cystic fibrosis.
Topics: Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnosis, Differential; Humans; Liver; Liver Diseases; Prognosis; Ursodeoxycholic Acid | 1998 |
[Hepatobiliary disease in cystic fibrosis].
Topics: Bile Duct Diseases; Biomarkers; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid | 1998 |
Mechanism of hepatoprotective action of bile salts in liver disease.
Topics: Animals; Cell Death; Cholagogues and Choleretics; Humans; Lipid Peroxidation; Liver; Liver Circulation; Liver Diseases; Ursodeoxycholic Acid | 1999 |
Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
Topics: Animals; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Liver Diseases; Pregnancy; Ursodeoxycholic Acid | 1999 |
Ursodeoxycholic acid therapy in hepatobiliary disease.
Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Cholagogues and Choleretics; Cystic Fibrosis; Humans; Liver Diseases; Ursodeoxycholic Acid | 2000 |
Use of ursodeoxycholic acid in liver diseases.
Topics: Cholagogues and Choleretics; Chronic Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 2001 |
Autoimmune liver disease. Current standards, future directions.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Prednisone; Prognosis; Ursodeoxycholic Acid | 2001 |
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.
Topics: Animals; Bile Duct Diseases; Chemical Phenomena; Chemistry, Physical; Humans; Liver Diseases; Ursodeoxycholic Acid | 2001 |
Use of ursodeoxycholic acid in patients with liver disease.
Topics: Cholagogues and Choleretics; Disease-Free Survival; Humans; Liver Diseases; Ursodeoxycholic Acid | 2002 |
Parenteral nutrition-associated liver complications in children.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bilirubin; Carnitine; Child; Cholestasis; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Parenteral Nutrition; Sepsis; Sincalide; Taurine; Ursodeoxycholic Acid | 2002 |
[Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope].
Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Dissolution of gallstones--when and how?
Topics: Bile; Chenodeoxycholic Acid; Cholecystography; Cholelithiasis; Drug Administration Schedule; Female; Humans; Liver Diseases; Obesity; Pregnancy; Ursodeoxycholic Acid | 1979 |
Liver disease in cystic fibrosis.
Topics: Cystic Fibrosis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
[New aspects of cystic fibrosis liver disease].
Topics: Adolescent; Cystic Fibrosis; Humans; Liver Diseases; Male; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid in chronic liver disease.
Topics: Animals; Cholestasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1991 |
[Bile acid therapy; new hope for patients with chronic liver diseases].
Topics: Cholangitis, Sclerosing; Cholelithiasis; Chronic Disease; Hepatitis, Chronic; Humans; Infant, Newborn; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid | 1991 |
17 trial(s) available for ursodeoxycholic acid and Liver Dysfunction
| Article | Year |
|---|---|
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.
Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.
Topics: Adult; Antioxidants; Humans; Liver; Liver Diseases; Male; Microbiota; MicroRNAs; Phenylalanine; Tyrosine; Ursodeoxycholic Acid; Vitamin E; Young Adult | 2018 |
Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.
Topics: Cysts; Humans; Liver Diseases; Polycystic Kidney, Autosomal Dominant; Quality of Life; Ursodeoxycholic Acid | 2016 |
A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
Topics: Administration, Oral; Child Development; Cholestasis; Double-Blind Method; Erythromycin; Feeding and Eating Disorders; Feeding Behavior; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition; Prospective Studies; Risk Assessment; Ursodeoxycholic Acid; Weight Gain | 2012 |
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Alanine Transaminase; Bilirubin; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Liver Diseases; Male; Middle Aged; Prospective Studies; Survival Analysis; Transplantation, Homologous; Ursodeoxycholic Acid | 2002 |
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
Topics: Adult; Aged; Cholagogues and Choleretics; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Patient Compliance; Placebos; Prednisone; Safety; Ursodeoxycholic Acid | 2007 |
The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
Topics: Adolescent; Adult; Child; Cholagogues and Choleretics; Cystic Fibrosis; Disease Progression; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Diseases; Liver Function Tests; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation.
Topics: Acute Disease; Cholagogues and Choleretics; Double-Blind Method; Female; Graft Rejection; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 1995 |
Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial.
Topics: Absorption; Adolescent; Adult; Bile Acids and Salts; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Fats; Female; Humans; Liver Diseases; Male; Nutritional Status; Placebos; Prospective Studies; Taurine; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
Topics: 5'-Nucleotidase; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Gastrointestinal Agents; Humans; Liver Diseases; Male; Nutritional Status; Prealbumin; Taurine; Ursodeoxycholic Acid | 1996 |
Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile Acids and Salts; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Liver Diseases; Male; Ursodeoxycholic Acid | 1996 |
Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control study.
Topics: Administration, Oral; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bone Marrow Transplantation; Double-Blind Method; Feces; Female; Humans; Liver Diseases; Lymphocyte Depletion; Male; Ursodeoxycholic Acid | 1996 |
A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Topics: Adolescent; Adult; Bile Acids and Salts; Child; Cystic Fibrosis; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Prospective Studies; Spectrometry, Mass, Fast Atom Bombardment; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children.
Topics: Child; Female; Humans; Liver Diseases; Male; Obesity; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.
Topics: Bile Acids and Salts; Cystic Fibrosis; Dose-Response Relationship, Drug; Duodenum; Enzymes; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.
Topics: Bilirubin; Cholestasis; Chronic Disease; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
A pharmacokinetic analysis of enterohepatic circulation of ursodeoxycholic acid, a drug with a high hepatic extraction but a small clearance.
Topics: Administration, Oral; Adult; Aged; Deoxycholic Acid; Enterohepatic Circulation; Female; Humans; Injections, Intravenous; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radioimmunoassay; Ursodeoxycholic Acid | 1988 |
118 other study(ies) available for ursodeoxycholic acid and Liver Dysfunction
| Article | Year |
|---|---|
Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report.
Topics: Bile Acids and Salts; Humans; Infant; Liver; Liver Diseases; Male; Oxysterols; Ursodeoxycholic Acid | 2022 |
Rolling stones: an instructive case of neonatal cholestasis.
Topics: Biliary Atresia; Choledocholithiasis; Cholestasis; Humans; Hyperbilirubinemia; Infant; Infant, Newborn; Infant, Newborn, Diseases; Jaundice, Neonatal; Liver Diseases; Male; Ursodeoxycholic Acid | 2022 |
Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
Topics: Animals; Bile Acids and Salts; Cholestasis; Female; Humans; Infant, Newborn; Liver Diseases; Male; Mice; Pregnancy; Ursodeoxycholic Acid | 2023 |
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC.
Topics: Cholangitis, Sclerosing; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Quality of Life; Surveys and Questionnaires; Ursodeoxycholic Acid | 2023 |
Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease.
Topics: Cholagogues and Choleretics; COVID-19; COVID-19 Vaccines; Humans; Liver Diseases; SARS-CoV-2; Ursodeoxycholic Acid | 2023 |
Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children.
Topics: Child; COVID-19; Hospitalization; Humans; Liver Diseases; SARS-CoV-2; Ursodeoxycholic Acid | 2023 |
Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Topics: Apoptosis; Bile Acids and Salts; Bilirubin; Cell Line, Tumor; Cholestasis; Down-Regulation; Genetic Profile; Humans; Lithocholic Acid; Liver; Liver Diseases; Osteoblasts; Osteoporosis; Osteosarcoma; Up-Regulation; Ursodeoxycholic Acid | 2020 |
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Ducts; Cell Proliferation; Cysts; Disease Models, Animal; Histone Deacetylase 6; Liver; Liver Diseases; Random Allocation; Rats; Synthetic Drugs; Ursodeoxycholic Acid | 2021 |
Congenital erythropoietic protoporphyria and protoporphyric hepatopathy in a dog.
Topics: Animals; Bile; Dog Diseases; Dogs; Liver; Liver Diseases; Male; Protoporphyria, Erythropoietic; Ursodeoxycholic Acid | 2020 |
Mefepronic acid is associated with a decrease in serum liver enzyme activities in dogs with suspected hepatopathy.
Topics: Animals; Dog Diseases; Dogs; Liver Diseases; Ursodeoxycholic Acid | 2021 |
Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
Topics: Apoptosis; Autoimmune Diseases; Bile Acids and Salts; Carcinoma, Hepatocellular; Caspase 3; Cholangitis, Sclerosing; Cholestanetriol 26-Monooxygenase; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Dietary Supplements; Down-Regulation; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fatty Acids, Omega-3; Gene Expression; Hep G2 Cells; Humans; Inflammation; Liver; Liver Cirrhosis, Biliary; Liver Diseases; THP-1 Cells; Ursodeoxycholic Acid | 2021 |
Hepatic actinomycosis with immunoglobulin G4-related liver disease: A case report.
Topics: Actinomycosis; Aged; Diagnosis, Differential; Granuloma, Plasma Cell; Humans; Immunoglobulin G; Liver; Liver Diseases; Male; Tomography, X-Ray Computed; Ursodeoxycholic Acid | 2018 |
[In process].
Topics: Cholagogues and Choleretics; Gallbladder Diseases; Humans; Liver Diseases; Ursodeoxycholic Acid | 2017 |
Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis.
Topics: Abdominal Pain; Adolescent; Biopsy; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Constipation; Contraceptives, Oral; Cystic Fibrosis; Female; Humans; Jaundice; Liver; Liver Diseases; Lung Diseases; Ovarian Cysts; Pancreas; Pancreatic Cyst; Pruritus; Radiography, Abdominal; Tomography, X-Ray Computed; Ursodeoxycholic Acid; Weight Loss | 2018 |
Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
Topics: Adolescent; Child; Cystic Fibrosis; Female; France; Humans; Incidence; Liver Diseases; Male; Retrospective Studies; Risk Factors; Ursodeoxycholic Acid; Young Adult | 2019 |
NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
Topics: Adenylate Kinase; alpha 1-Antitrypsin; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Disease Models, Animal; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Diseases; Mice; Mutant Proteins; Proteolysis; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Ursodeoxycholic Acid | 2018 |
Therapeutics Highlights from ILC 2018, the EASL annual congress.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bezafibrate; Budesonide; CCR5 Receptor Antagonists; Congresses as Topic; Fibroblast Growth Factors; Gastrointestinal Agents; Humans; Imidazoles; Liver Diseases; Pyridazines; Sulfoxides; Uracil; Ursodeoxycholic Acid | 2018 |
Diagnosis of primary biliary cholangitis in a "teen" male patient.
Topics: Age Factors; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholangitis; Cholestasis, Intrahepatic; Humans; Liver Diseases; Male; Thyroiditis, Autoimmune; Ursodeoxycholic Acid; Young Adult | 2019 |
Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Male; Medication Adherence; Middle Aged; Prospective Studies; Ursodeoxycholic Acid; Young Adult | 2019 |
Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cell Differentiation; Dogs; Gene Expression Regulation; Humans; Hybridomas; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Lysosomal-Associated Membrane Protein 2; Madin Darby Canine Kidney Cells; Molecular Sequence Data; Prognosis; Protein Binding; Recombinant Proteins; RNA, Messenger; Tissue Distribution; Ursodeoxycholic Acid | 2013 |
[Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Crohn Disease; Drug Therapy, Combination; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid | 2013 |
[Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: the RACURS study].
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Gallbladder Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Diseases; Middle Aged; Risk; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Ducts; Calcium; Cell Proliferation; Cells, Cultured; Cholagogues and Choleretics; Cysts; Disease Models, Animal; Liver; Liver Diseases; Rats; Tandem Mass Spectrometry; Ursodeoxycholic Acid | 2015 |
Ursodeoxycholic Acid for Treatment of Enlarged Polycystic Liver.
Topics: Aged; Alkaline Phosphatase; Cholagogues and Choleretics; Cysts; Drug Monitoring; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Male; Middle Aged; Organ Size; Polycystic Kidney Diseases; Renal Dialysis; Tomography, X-Ray Computed; Treatment Outcome; Ursodeoxycholic Acid | 2016 |
Liver Sarcoidosis with Unique MRI Images Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid.
Topics: Female; Gadolinium DTPA; Humans; Liver Diseases; Magnetic Resonance Imaging; Middle Aged; Sarcoidosis; Tomography, X-Ray Computed; Ursodeoxycholic Acid | 2015 |
Supplementation of ursodeoxycholic acid improves fat digestion and absorption in cystic fibrosis patients with mild liver involvement.
Topics: Adolescent; Adult; Breath Tests; Carbon Isotopes; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Dietary Fats; Dietary Supplements; Female; Humans; Liver Diseases; Male; Triglycerides; Ursodeoxycholic Acid; Young Adult | 2016 |
The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study.
Topics: Adult; Aged; Chemoprevention; Cholagogues and Choleretics; Cohort Studies; Colorectal Neoplasms; Databases, Factual; Female; Humans; Incidence; Liver Diseases; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Taiwan; Ursodeoxycholic Acid | 2016 |
Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
Topics: Adolescent; Adult; Bile Acids and Salts; Biotransformation; Child; Child, Preschool; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Lithocholic Acid; Liver Diseases; Male; Tandem Mass Spectrometry; Ursodeoxycholic Acid; Young Adult | 2016 |
Cystic Fibrosis Liver Disease and Ursodeoxycholic Acid: One Small Step Forward, Miles to Go.
Topics: Bile Acids and Salts; Cystic Fibrosis; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid | 2016 |
Hepatic sarcoidosis: a case series.
Topics: Adult; Biopsy; Female; Glucocorticoids; Granuloma; Humans; Liver Diseases; Male; Middle Aged; Retrospective Studies; Sarcoidosis; Treatment Outcome; Ursodeoxycholic Acid | 2016 |
Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
Topics: Alanine Transaminase; alpha 1-Antitrypsin Deficiency; Aspartate Aminotransferases; Bilirubin; Child; Child, Preschool; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Infant; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Phenotype; Recurrence; Retrospective Studies; Ursodeoxycholic Acid | 2008 |
Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis.
Topics: Adult; Aged; Amyloidosis; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 2009 |
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Topics: Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant; Italy; Liver Diseases; Male; Morbidity; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Topics: Bilirubin; Biomarkers; Child; Child, Preschool; Cholestasis, Intrahepatic; Enteral Nutrition; Enterocolitis, Necrotizing; Fat Emulsions, Intravenous; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Diseases; Intestinal Obstruction; Intestine, Small; Intestines; Liver Diseases; Organ Transplantation; Parenteral Nutrition; Patient Care Team; Postoperative Complications; Referral and Consultation; Rehabilitation Centers; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
[Usefulness of ursodeoxycholic acid in a case of hepatic sarciodosis].
Topics: Adult; Cholagogues and Choleretics; Humans; Liver Diseases; Male; Sarcoidosis; Ursodeoxycholic Acid | 2010 |
Titration of bile acid supplements in 3beta-hydroxy-Delta 5-C27-steroid dehydrogenase/isomerase deficiency.
Topics: 3-Hydroxysteroid Dehydrogenases; Biopsy; Chenodeoxycholic Acid; Child; Child, Preschool; Cholagogues and Choleretics; Cholic Acids; Chromatography, Liquid; Dietary Supplements; Disease Progression; Humans; Infant; Infant, Newborn; Isomerases; Liver Diseases; Steroid Metabolism, Inborn Errors; Tandem Mass Spectrometry; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Antibiotic treatment is superior to ursodeoxycholic acid on total parenteral nutrition associated hepatic dysfunction.
Topics: Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Bilirubin; Caspase 3; Fas Ligand Protein; Gentamicins; Immunoenzyme Techniques; In Situ Nick-End Labeling; Liver Diseases; Malondialdehyde; Metronidazole; Oxidative Stress; Parenteral Nutrition, Total; Peroxidase; Rabbits; Ursodeoxycholic Acid | 2010 |
[Bile acids in norm and pathology].
Topics: Bile; Bile Acids and Salts; Biological Transport; Cholagogues and Choleretics; Humans; Lipid Metabolism; Liver Diseases; Molecular Structure; Ursodeoxycholic Acid | 2010 |
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholangitis; Cholestasis; Chromatography, Gas; Hepatoblastoma; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Rats; Rats, Sprague-Dawley; Taurine; Taurolithocholic Acid; Ursodeoxycholic Acid | 2010 |
[Intrahepatic cholestasis in chronic liver diseases].
Topics: Blood Coagulation; Cholestasis, Intrahepatic; Chronic Disease; Drug Therapy, Combination; Humans; Liver Diseases; Liver Function Tests; Prognosis; Quality of Life; S-Adenosylmethionine; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Topics: Bile Acids and Salts; Biliary Tract Diseases; Cholagogues and Choleretics; Cholangitis, Sclerosing; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Prevention and treatment of intestinal failure-associated liver disease in children.
Topics: Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Liver; Humans; Intestinal Diseases; Liver Cirrhosis; Liver Diseases; Parenteral Nutrition; Ursodeoxycholic Acid | 2012 |
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Drug Interactions; Female; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Immunotoxins; Liver Diseases; Male; Middle Aged; Myelodysplastic Syndromes; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Time Factors; Ursodeoxycholic Acid | 2002 |
Diagnosis and management of hepatic copper accumulation in a Skye terrier.
Topics: Animals; Ascites; Colchicine; Copper; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Liver; Liver Diseases; Radiography; Seizures; Ultrasonography; Ursodeoxycholic Acid; Vomiting; Zinc | 2003 |
Ursodeoxycholic acid treatment of idiopathic thrombocytopenic purpura with liver dysfunction.
Topics: Adult; Fatty Liver; Female; Humans; Liver Diseases; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Ursodeoxycholic Acid | 2003 |
Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Cholic Acid; Cystic Fibrosis; Female; Humans; Infant; Liver Diseases; Male; Predictive Value of Tests; Prognosis; Ursodeoxycholic Acid | 2004 |
[Treatment of autoimmune hepatic diseases].
Topics: Adult; Autoimmune Diseases; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Prognosis; Risk Factors; Syndrome; Time Factors; Ursodeoxycholic Acid | 2004 |
Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hypertension, Portal; Liver Diseases; Male; Middle Aged; Portal Vein; Time Factors; Treatment Outcome; Ultrasonography; Ultrasonography, Doppler; Ursodeoxycholic Acid | 2005 |
Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Prospective Studies; Transplantation Conditioning; Ursodeoxycholic Acid | 2005 |
[Non-hepatic manifestations of the overlap syndrome (a case report)].
Topics: Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Diagnosis, Differential; Drug Therapy, Combination; Dry Eye Syndromes; Female; Humans; Liver Diseases; Middle Aged; Syndrome; Ursodeoxycholic Acid; Xerostomia | 2006 |
Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Topics: Alanine Transaminase; Animals; Bile Acids and Salts; Body Weight; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cricetinae; Eating; Liver; Liver Diseases; Mesocricetus; Ursodeoxycholic Acid | 2007 |
Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemokine CXCL2; Cholagogues and Choleretics; Concanavalin A; Dose-Response Relationship, Drug; Gene Expression Regulation; Interferon-gamma; Interleukins; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; RNA, Messenger; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2008 |
Anabolic-androgenic steroids and liver injury.
Topics: Adult; Anabolic Agents; Androgens; Chemical and Drug Induced Liver Injury; Cholestasis; Hepatomegaly; Humans; Liver Diseases; Male; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Immunosuppressive Agents; Lipid Peroxidation; Liver Diseases; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2008 |
A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
Topics: Adult; Cholagogues and Choleretics; Comorbidity; Cystic Fibrosis; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Platelet Count; Prospective Studies; Splenomegaly; Thrombocytopenia; Ursodeoxycholic Acid | 2008 |
[Extrasecretory liver function disorder in patients with chronic pancreatitis].
Topics: Abdominal Pain; Adult; Bile; Cholagogues and Choleretics; Female; Gallbladder; Humans; Liver; Liver Diseases; Male; Middle Aged; Pancreatitis, Chronic; Sphincter of Oddi; Ursodeoxycholic Acid | 2007 |
[Jeune'disease (asphyxiating thoracic dystrophy) and respiratory failure: importance of early respiratory management with periodic hyperinsufflation].
Topics: Child; Child, Preschool; Disease Management; Female; Fetal Diseases; Genes, Recessive; Humans; Infant; Infant, Newborn; Insufflation; Liver Diseases; Male; Osteochondrodysplasias; Prenatal Diagnosis; Respiration, Artificial; Respiratory Insufficiency; Ribs; Tracheostomy; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid.
Topics: Adult; Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Female; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1983 |
[Significance and limitations of oral UDCA loading in liver function test].
Topics: Bile Acids and Salts; Biological Availability; Deoxycholic Acid; Diagnosis, Differential; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Ursodeoxycholic Acid | 1984 |
[Hepatology in 1981].
Topics: Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholelithiasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Peliosis Hepatis; Peritoneovenous Shunt; Ursodeoxycholic Acid | 1981 |
Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man.
Topics: Adult; Aged; Chenodeoxycholic Acid; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1982 |
[Change of serum bile acids levels after administration of UDCA and test meals (author's transl)].
Topics: Bile Acids and Salts; Deoxycholic Acid; Humans; Liver Diseases; Ursodeoxycholic Acid | 1982 |
Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
Topics: Animals; Bile Canaliculi; Body Weight; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cytoskeleton; Deoxycholic Acid; Lithocholic Acid; Liver; Liver Diseases; Prognosis; Rabbits; Ursodeoxycholic Acid | 1982 |
[A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay (author's transl)].
Topics: Biliary Tract Diseases; Deoxycholic Acid; Drug Tolerance; Humans; Liver Diseases; Radioimmunoassay; Ursodeoxycholic Acid | 1981 |
[A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].
Topics: Administration, Oral; Bile Acids and Salts; Deoxycholic Acid; Fasting; Humans; Liver Diseases; Ursodeoxycholic Acid | 1981 |
Hepatotoxic effect of bile acids in inflammatory bowel disease.
Topics: Adult; Aged; Bile Acids and Salts; Biotransformation; Colitis, Ulcerative; Crohn Disease; Female; Humans; Lithocholic Acid; Liver; Liver Diseases; Male; Middle Aged; Stereoisomerism; Sulfates; Ursodeoxycholic Acid | 1980 |
[Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid].
Topics: Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Diseases; Liver Function Tests; Male; Phenobarbital; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid | 1993 |
Regulation of bile acid synthesis by deoxycholic acid in the rat: different effects on cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase.
Topics: Animals; Bile; Bile Acids and Salts; Cell Nucleus; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestanetriol 26-Monooxygenase; Cholesterol 7-alpha-Hydroxylase; Cytochrome P-450 Enzyme System; Deoxycholic Acid; Diet; Hydroxymethylglutaryl CoA Reductases; Liver; Liver Diseases; Male; Necrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid Hydroxylases; Ursodeoxycholic Acid | 1995 |
Metabolism, pharmacokinetics, and activity of a new 6-fluoro analogue of ursodeoxycholic acid in rats and hamsters.
Topics: Albumins; Animals; Bile; Chemical and Drug Induced Liver Injury; Cricetinae; Hydrogen-Ion Concentration; Liver Diseases; Male; Mesocricetus; Protein Binding; Rats; Rats, Sprague-Dawley; Solubility; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1995 |
[The influence of bear acid on lipid metabolism. A future drug?].
Topics: Animals; Cholelithiasis; Humans; Lipid Metabolism; Liver; Liver Diseases; Ursidae; Ursodeoxycholic Acid | 1995 |
[Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment].
Topics: Acetylglucosamine; Bile Acids and Salts; Chronic Disease; Humans; Liver Diseases; Middle Aged; Ursodeoxycholic Acid | 1995 |
Treatment with Ursodeoxycholic Acid in Clinical Hepatology. Proceedings of a workshop. Goteborg, Sweden, 3-4 February 1994.
Topics: Animals; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis.
Topics: Chronic Disease; DNA; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Ursodeoxycholic Acid | 1994 |
Effect of ursodeoxycholic acid on in vivo and in vitro toxic liver injury in rats.
Topics: Acetaminophen; Administration, Oral; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Ethanol; Lipid Peroxides; Liver; Liver Diseases; Male; Rats; Ursodeoxycholic Acid; Valine | 1994 |
[Clinical significance of 3 beta, 7 beta-dihydroxy-5 beta-cholan-24-oic acid (isoUDCA) in serum during administration of ursodeoxycholic acid].
Topics: Chenodeoxycholic Acid; Humans; Liver Diseases; Ursodeoxycholic Acid | 1993 |
Effects of selective zonal injury on bile acid-induced bile flow in the isolated rat liver.
Topics: Animals; Bile; Bile Acids and Salts; Biotransformation; Chenodeoxycholic Acid; Cholagogues and Choleretics; In Vitro Techniques; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Taurocholic Acid; Ursodeoxycholic Acid | 1993 |
Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study.
Topics: Animals; Bile Acids and Salts; Bile Duct Diseases; Cholesterol; Female; Liver Diseases; Parenteral Nutrition, Total; Rabbits; Sulfobromophthalein; Time Factors; Ursodeoxycholic Acid | 1993 |
The role of hepatobiliary scintigraphy in cystic fibrosis.
Topics: Adolescent; Adult; Biliary Tract; Child; Child, Preschool; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Infant; Liver; Liver Diseases; Male; Prospective Studies; Radionuclide Imaging; Taurine; Ultrasonography; Ursodeoxycholic Acid | 1996 |
Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
Topics: Anticholesteremic Agents; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |
Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile; Chemical and Drug Induced Liver Injury; Cholangitis; Cholic Acids; Drug Resistance, Multiple; Food, Formulated; Gene Expression; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Mice; Mice, Mutant Strains; Ursodeoxycholic Acid | 1996 |
Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
Topics: Adult; Aged; Bile Acids and Salts; Chronic Disease; Female; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Sulfates; Ursodeoxycholic Acid | 1996 |
Bile acid research and applications.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Pregnancy; Pregnancy Complications; Research; Ursodeoxycholic Acid | 1997 |
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid | 1997 |
Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Liver; Liver Diseases; Middle Aged; Sarcoidosis; Ursodeoxycholic Acid | 1997 |
The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females.
Topics: Animals; Bile Acids and Salts; Diet; Female; Genes, MDR; Liver Diseases; Male; Mice; Mice, Knockout; Sex Characteristics; Solubility; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid; Water | 1997 |
Hepatic complications of erythropoietic protoporphyria.
Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Coproporphyrins; Female; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Porphyria, Hepatoerythropoietic; Protoporphyrins; Ursodeoxycholic Acid | 1998 |
Assessment of biliary bicarbonate secretion in humans by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Bicarbonates; Bile Ducts; Biliary Tract Diseases; Cholestasis, Extrahepatic; Female; Gastrointestinal Agents; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Reference Values; Secretin; Sodium Bicarbonate; Tomography, Emission-Computed; Ursodeoxycholic Acid | 1999 |
Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.
Topics: Adolescent; Adult; Bile Ducts; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Intestines; Liver; Liver Diseases; Male; Radionuclide Imaging; Time Factors; Treatment Failure; Ultrasonography; Ursodeoxycholic Acid | 1999 |
Jeune syndrome and liver disease: report of three cases treated with ursodeoxycholic acid.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Asphyxia Neonatorum; Child; Child, Preschool; Cholagogues and Choleretics; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Osteochondrodysplasias; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Autoimmune cholangitis within the spectrum of autoimmune liver disease.
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; HLA Antigens; Humans; Liver Diseases; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid | 2000 |
The chronic disease of childhood obesity: the sleeping giant has awakened.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Chronic Disease; Fatty Liver; Health Promotion; Humans; Life Style; Liver Diseases; Obesity; Ursodeoxycholic Acid | 2000 |
Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Liver Diseases; Liver Function Tests; Longitudinal Studies; Male; Prospective Studies; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2001 |
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Topics: Alkaline Phosphatase; Animals; Bile Acids and Salts; Carrier Proteins; Chenodeoxycholic Acid; Humans; Hydroxysteroid Dehydrogenases; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2000 |
[Ursodeoxycholic acid as the main treatment of hepatobiliary diseases in children and teenagers].
Topics: Adolescent; Bile Duct Diseases; Child; Humans; Liver Diseases; Ursodeoxycholic Acid | 2001 |
Hepatic hydroxylation of bile acids and chronic liver diseases: do transporters play a mechanistic role?
Topics: Bile Acids and Salts; Biliary Tract Diseases; Carrier Proteins; Chronic Disease; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Humans; Hydroxylation; Liver; Liver Diseases; Membrane Transport Proteins; Organic Anion Transporters, Sodium-Dependent; Symporters; Ursodeoxycholic Acid | 2001 |
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study.
Topics: Aged; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Flutamide; Humans; Liver Diseases; Male; Prostatic Neoplasms; Retrospective Studies; Ursodeoxycholic Acid | 2002 |
[Ursotherapy in hepatobiliary diseases].
Topics: Chenodeoxycholic Acid; Cholelithiasis; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Chronic graft-vs.-host disease of the liver: another indication of ursodeoxycholic acid?
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
[Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
Topics: Adult; Aged; Chronic Disease; Clinical Enzyme Tests; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Regression Analysis; Transaminases; Ursodeoxycholic Acid | 1992 |
Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.
Topics: Adolescent; Bile Ducts; Child; Cystic Fibrosis; Female; Humans; Liver; Liver Diseases; Male; Radionuclide Imaging; Ursodeoxycholic Acid | 1992 |
Lithocholic acid accumulation.
Topics: Animals; Chronic Disease; Humans; Lithocholic Acid; Liver; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Liver and biliary problems in cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Animals; Biliary Tract Diseases; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Liver Transplantation; Male; Rats; Ursodeoxycholic Acid | 1992 |
Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
Topics: Acetylglucosamine; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Deoxycholic Acid; Glycosides; Humans; Hydroxylation; Liver Diseases; Mass Spectrometry; Ursodeoxycholic Acid | 1992 |
Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Griseofulvin; Liver Diseases; Mice; Mice, Inbred ICR; Microscopy, Electron; Porphobilinogen; Porphyrias; Ursodeoxycholic Acid | 1991 |
Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
Topics: Adult; Aminopyrine; Bile; Bile Acids and Salts; Carbon Isotopes; Carbon Radioisotopes; Cholestasis; Female; Humans; Intestines; Liver Diseases; Male; Microsomes, Liver; Middle Aged; Ursodeoxycholic Acid | 1991 |
[The influence of ursodesoxycholic acid (URSO) on griseofulvin (GF)-induced protoporphyria].
Topics: Animals; Chemical and Drug Induced Liver Injury; Griseofulvin; Liver Diseases; Male; Mice; Mice, Inbred Strains; Porphyrias; Protoporphyrins; Ursodeoxycholic Acid | 1991 |
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid | 1991 |
Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Topics: Absorption; Animals; Bile; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis, Intrahepatic; Cholic Acid; Cholic Acids; Female; Griseofulvin; Liver; Liver Diseases; Mice; Protoporphyrins; Structure-Activity Relationship; Ursodeoxycholic Acid | 1991 |
Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract Diseases; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Liver Diseases; Microscopy, Electron; Perfusion; Porphyrins; Protoporphyrins; Rats; Rats, Inbred Strains; Taurocholic Acid; Ursodeoxycholic Acid | 1990 |
Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Topics: Adolescent; Bile Acids and Salts; Child; Chromatography, High Pressure Liquid; Cystic Fibrosis; Deoxycholic Acid; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver Diseases; Male; Mass Spectrometry; Ursodeoxycholic Acid | 1990 |
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Child; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Liver Diseases; Liver Function Tests; Male; Taurine; Ursodeoxycholic Acid | 1990 |
[Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis].
Topics: Cholestyramine Resin; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Porphyrias; Porphyrins; Protoporphyrins; Sepsis; Ursodeoxycholic Acid | 1989 |
[The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
Topics: Adult; Biliary Tract; Chronic Disease; Deoxycholic Acid; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pyridoxal; Radionuclide Imaging; Tryptophan; Ursodeoxycholic Acid | 1988 |
[Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
Topics: Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Glucagon; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Ursodeoxycholic Acid | 1988 |
Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
Topics: Animals; Bile Acids and Salts; Deoxycholic Acid; Liver; Liver Diseases; Rabbits; Ursodeoxycholic Acid | 1986 |
[The oral ursodeoxycholic acid test and its value in the diagnosis of liver diseases].
Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Deoxycholic Acid; Diagnosis, Differential; Evaluation Studies as Topic; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 1986 |
[Bile acids in chronic hepatopathies].
Topics: Adult; Bile Acids and Salts; Cholestasis; Chronic Disease; Diagnosis, Differential; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Middle Aged; Ursodeoxycholic Acid | 1986 |